InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Peraza Lisa, Vice-Présidente, Directrice Comptable. Insider active across 2 companies, notably Heron Therapeutics, INC.. Cumulatively, 14 filings have been published. History available since 30 April 2021. The latest transaction was filed on 30 April 2021 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
552 sharesCommon StockSEC:0001209191-24-001626:0
42,631 sharesCommon StockSEC:0001209191-23-053030:0
552 sharesCommon StockSEC:0001209191-23-042479:0
552 sharesCommon StockSEC:0001209191-23-024498:0
552 sharesCommon StockSEC:0001209191-23-003561:0
553 sharesCommon StockSEC:0001209191-22-053832:0
552 sharesCommon StockSEC:0001209191-22-042260:0
552 sharesCommon StockSEC:0001209191-22-024520:0
552 sharesCommon StockSEC:0001209191-22-003360
552 sharesCommon StockSEC:0001209191-22-003360:0
552 sharesCommon StockSEC:0001209191-21-060549:0
552 sharesCommon StockSEC:0001209191-21-060549
1,530 shares@ US$13.89750.0072% mcap50.0% of flowCommon StockSEC:0001209191-21-046788:0
1,530 shares@ US$13.897550.0% of flowCommon StockSEC:0001209191-21-046788
14 of 14 declarations
About Peraza Lisa
Lisa Peraza serves as the VP, Chief Accounting Officer at HERON THERAPEUTICS, INC. She oversees the company's accounting functions, ensuring compliance and operational efficiency. Peraza brings expertise in accounting and financial management, contributing to strategic decisions that promote the company's growth. Her commitment to financial transparency enhances trust among investors and stakeholders.
